- To complete this test successfully, answer all questions obtaining 10/10.
- You can repeat the test all the times you need but remember to answer all questions.
- You will require 30 minutes approximately to complete all the questions.
Test Summary
0 of 10 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
Information
You have already completed the test before. Hence you can not start it again.
Test is loading…
You must sign in or sign up to start the test.
You must first complete the following:
Results
Results
0 of 10 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Answered
- Review
-
Question 1 of 10
1. Question
How common is ovarian cancer?
CorrectIncorrect -
Question 2 of 10
2. Question
Considering the different clinicopathological types of ovarian cancer:
CorrectIncorrect -
Question 3 of 10
3. Question
The reasons for considering germinal gene testing in ovarian cancer are:
CorrectIncorrect -
Question 4 of 10
4. Question
Gene testing in ovarian cancer should be perfomed in:
CorrectIncorrect -
Question 5 of 10
5. Question
With is the frequency of pathogenic variants in genes associated with high-grade serous ovarian cancer?
CorrectIncorrect -
Question 6 of 10
6. Question
Considering the variants of uncertain significance (VUS):
CorrectIncorrect -
Question 7 of 10
7. Question
Regarding the evidence of ovarian cancer risk associated to each gene, it is false that:
CorrectIncorrect -
Question 8 of 10
8. Question
Considering the management of carriers of deleterious variants in high risk genes for ovarian cancer such as BRCA1, BRCA2 , RAD51C , RAD51D or BRIP1 :
CorrectIncorrect -
Question 9 of 10
9. Question
Which of the following genes are not involved in the homologous recombination DNA repair pathway?
CorrectIncorrect -
Question 10 of 10
10. Question
In relation with the maintenance studies with PARP inhibitors in ovarian cancer, it is false:
CorrectIncorrect